Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

UroToday - Ashish Kamat is joined by Wassim Kassouf, an expert in the bladder cancer field on Bacillus Calmette-Guérin unresponsive disease. Together they discuss the different...

UroToday - Phil Koo, MD, and Wolfgang Weber, MD, to share his thoughts on the current state of PSMA based therapies. Dr. Weber discusses which patients...

UroToday - Ashish Kamat is joined by Wassim Kassouf, an expert in the bladder cancer field on Bacillus Calmette-Guérin unresponsive disease. Together they discuss the different...

VJOncology - Laurence Klotz, MD, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Canada, discusses a prospective analysis...

CaboPoint: second-line cabozantinib for RCC

posted 2 months

Shared 0 times

VJOncology - Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, discusses the CaboPoint trial (NCT03945773). This study focuses on cabozantinib...

VJOncology - James Eastham, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses how genomics is going to markedly change...

VJOncology - Guru Sonpavde, MD, Dana-Farber Cancer Institute, Boston, MA, outlines his research highlights from the 2020 ASCO GU meeting. Dr...

UroToday - Hannah Rush joins Alicia Morgans discussing the quality of life outcomes we have seen from patients receiving docetaxel or abiraterone in the STAMPEDE trial....

UroToday - Alicia Morgans is joined by Felix Feng to discuss his recent presentation on a new analysis from the Phase III RTOG 9601 trial. They...